Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception

被引:50
作者
Clark, MK
Sowers, M
Levy, BT
Tenhundfeld, P
机构
[1] Univ Iowa, Coll Nursing, Iowa City, IA 52242 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
关键词
depot medroxyprogesterone; estradiol; progesterone; contraception;
D O I
10.1016/S0015-0282(01)01748-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To describe the magnitude and variability of sequential serum estradiol and progesterone concentrations throughout one depot medroxyprogesterone (DMPA) injection interval. Design: Prospective study. Setting: Family planning and women's health clinics. Patient(s): Thirty-one women, ages 19 to 46, using DMPA for contraception. Intervention(s): Serum for estrogen and progesterone was collected weekly throughout one DMPA injection interval. Main Outcome Measure(s): Serum estradiol and progesterone concentrations: estradiol patterns produced from data plotted across the entire DMPA injection interval. Result(s): The average daily estradiol concentrations ranged from 7.9 to 69.1 pg/mL, with a mean of 18.9 +/- 12.9 and a median of 15.4 pg/mL. Average daily progesterone concentrations ranged from 0.14 to 1.1 ng/mL, with a mean of 0.40 +/- 0.19 ng/mL and a median of 0.36 ng/mL. Two general patterns of estradiol concentrations were identified. One pattern. observed in approximately one third of the participants, reflected estradiol concentrations that were extremely low (mean, 12.7 +/- 3.6 pg/mL; median, 13.3 pg/mL) and consistently hat across the DMPA injection interval. The second pattern. seen in the remaining participants, reflected estradiol concentrations that were higher (mean, 22.2 +/- 14.9 pg/mL, median, 17.3 pg/mL) and quits variable. Conclusion(s): This study demonstrated that estradiol concentrations were lower than the 40 to 50 pg/mL reported in most studies and, for the majority of women, varied substantially across the DMPA injection interval. (Fertil Steril(R) 2001;75:871-7. (C)2001 by American Society for Reproductive Medicine.).
引用
收藏
页码:871 / 877
页数:7
相关论文
共 23 条
[1]   Forearm bone density in users of Depo-Provera as a contraceptive method [J].
Bahamondes, L ;
Perrotti, M ;
Castro, S ;
Faúndes, D ;
Petta, C ;
Bedone, A .
FERTILITY AND STERILITY, 1999, 71 (05) :849-852
[2]  
BYYNY RL, 1990, CLIN GUIDE CARE OLDE
[3]   Depot medroxyprogesterone acetate and breast cancer - A review of current knowledge [J].
Chilvers, CED .
DRUG SAFETY, 1996, 15 (03) :212-218
[4]   A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives [J].
Cromer, BA ;
Blair, JM ;
Mahan, JD ;
Zibners, L ;
Naumovski, Z .
JOURNAL OF PEDIATRICS, 1996, 129 (05) :671-676
[5]   RECOVERY OF BONE-DENSITY IN WOMEN WHO STOP USING MEDROXYPROGESTERONE ACETATE [J].
CUNDY, T ;
CORNISH, J ;
EVANS, MC ;
ROBERTS, H ;
REID, IR .
BRITISH MEDICAL JOURNAL, 1994, 308 (6923) :247-248
[6]   Spinal bone density in women using depot medroxyprogesterone contraception [J].
Cundy, T ;
Cornish, J ;
Roberts, H ;
Elder, H ;
Reid, IR .
OBSTETRICS AND GYNECOLOGY, 1998, 92 (04) :569-573
[7]   BONE-DENSITY IN WOMEN RECEIVING DEPOT MEDROXYPROGESTERONE ACETATE FOR CONTRACEPTION [J].
CUNDY, T ;
EVANS, M ;
ROBERTS, H ;
WATTIE, D ;
AMES, R ;
REID, IR .
BRITISH MEDICAL JOURNAL, 1991, 303 (6793) :13-16
[8]   LONG-TERM USE OF DEPOT MEDROXY PROGESTERONE ACETATE AS A CONTRACEPTIVE [J].
ELMAHGOUB, S ;
KARIM, M ;
AMMAR, R .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1972, 51 (03) :251-+
[9]  
Fraser I S, 1981, Med J Aust, V1, P3
[10]   Bone density in long term users of depot medroxyprogesterone acetate [J].
Gbolade, B ;
Ellis, S ;
Murby, B ;
Randall, S ;
Kirkman, R .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (07) :790-794